AU2002360062A1 - Tumour peptide antigen derived from the human cd19 protein - Google Patents
Tumour peptide antigen derived from the human cd19 proteinInfo
- Publication number
- AU2002360062A1 AU2002360062A1 AU2002360062A AU2002360062A AU2002360062A1 AU 2002360062 A1 AU2002360062 A1 AU 2002360062A1 AU 2002360062 A AU2002360062 A AU 2002360062A AU 2002360062 A AU2002360062 A AU 2002360062A AU 2002360062 A1 AU2002360062 A1 AU 2002360062A1
- Authority
- AU
- Australia
- Prior art keywords
- protein
- human
- peptide antigen
- antigen derived
- tumour peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10163755.1 | 2001-12-27 | ||
DE2001163755 DE10163755A1 (de) | 2001-12-27 | 2001-12-27 | Tumor-Peptidantigene aus humanem CD19-Protein |
PCT/EP2002/014598 WO2003055907A1 (fr) | 2001-12-27 | 2002-12-19 | Antigene peptidique tumoral issu de la proteine cd19 humaine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002360062A1 true AU2002360062A1 (en) | 2003-07-15 |
Family
ID=7710719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002360062A Abandoned AU2002360062A1 (en) | 2001-12-27 | 2002-12-19 | Tumour peptide antigen derived from the human cd19 protein |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002360062A1 (fr) |
DE (1) | DE10163755A1 (fr) |
WO (1) | WO2003055907A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA44909A (fr) | 2015-09-15 | 2018-07-25 | Acerta Pharma Bv | Association thérapeutique d'un inhibiteur du cd19 et d'un inhibiteur de la btk |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5820866A (en) * | 1994-03-04 | 1998-10-13 | National Jewish Center For Immunology And Respiratory Medicine | Product and process for T cell regulation |
US20010007152A1 (en) * | 1996-03-05 | 2001-07-05 | Linda A. Sherman | Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
-
2001
- 2001-12-27 DE DE2001163755 patent/DE10163755A1/de not_active Withdrawn
-
2002
- 2002-12-19 AU AU2002360062A patent/AU2002360062A1/en not_active Abandoned
- 2002-12-19 WO PCT/EP2002/014598 patent/WO2003055907A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003055907A1 (fr) | 2003-07-10 |
DE10163755A1 (de) | 2004-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003296330A1 (en) | Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions | |
AU2003262094A1 (en) | Cancer antigen peptide preparation | |
EP1365022A4 (fr) | Proteine associee a l'adiponectine | |
GB0218205D0 (en) | Human ZZAP1 protein | |
GB0108079D0 (en) | Protein | |
AU2002349543A1 (en) | Tumor antigens | |
AU2002360062A1 (en) | Tumour peptide antigen derived from the human cd19 protein | |
AU2002318186A1 (en) | Novel human kielin-like proteins and polynucleotides encoding the same | |
AU2002365148A1 (en) | Human ras interacting protein | |
IL161804A0 (en) | Protein knobs | |
AU2002360333A1 (en) | Human angiomotin-like protein 1 | |
AU2002362494A1 (en) | Tumor-peptide antigens from the human prdi-bf1-protein | |
AU2002257630A1 (en) | Human mrp5-like protein | |
AU2002245593A1 (en) | Novel human dectin proteins and polynucleotides encoding the same | |
AU2002306319A1 (en) | Tumor antigen | |
AU2002242505A1 (en) | Tumor associated proteins | |
GB0106318D0 (en) | Protein | |
AU2002235925A1 (en) | Tumour peptide antigen produced from human mdm2 proto-oncogene | |
AU2002362927A1 (en) | Human gtp-activator protein for rab-like gtpase | |
AU2001273081A1 (en) | Peptide combination for the treatment of cancer | |
GB0201819D0 (en) | Human posh-like protein 1 | |
GB0201681D0 (en) | Human ralgds-like protein 3 | |
AU2002302838A1 (en) | Cancer associated protein | |
AUPR664401A0 (en) | Rb-binding protein 2 | |
GB0113705D0 (en) | Therapeutic peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |